Supplementary Table S1 from Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

Authors :: John V. Heymach
Ignacio I. Wistuba
Jing Wang
Andrew Futreal
James P. Allison
John D. Minna
Waun K. Hong
Gordon B. Mills
Padmanee Sharma
Jianhua Zhang
Kwok-Kin Wong
Roy S. Herbst
John N. Weinstein
Vincent Miller
Garrett M. Frampton
Murim Choi
Timothy P. Heffernan
Carlo Toniatti
Kevin R. Coombes
Luc Girard
Michael Peyton
Youhong Fan
Chao Yang
Maria A. Cortez
Jayanthi Gudikote
Uma Giri
Jianjun Zhang
Jaime Rodriguez Canales
Edwin R. Parra
Humam Kadara
Carmen Behrens
Julie Izzo
Pan Tong
Vassiliki A. Papadimitrakopoulou
Lixia Diao
Lauren A. Byers
Ferdinandos Skoulidis
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Table S1. Individual KRAS, STK11/LKB1, TP53, ATM and KEAP1 somatic mutations from the indicated clinical cohorts.

Tools